| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/16/2008 | US7425545 Antisense oligonucleotide for use in controlling c-reactive protein expression and treatment and prevention of adipocyte differentiation, obesity, hyperlipidemia, atherosclerosis and hypertension |
| 09/16/2008 | US7425544 Modulation of eIF4E expression |
| 09/16/2008 | US7425536 Feline hepatocyte growth factor |
| 09/16/2008 | US7425530 Stereoselective preparation of cyclic L-amino acids |
| 09/16/2008 | US7425450 Regulatable growth of filamentous fungi |
| 09/16/2008 | US7425449 Site specific Listeria integration vectors and methods for using the same |
| 09/16/2008 | US7425448 Cells for use as models in the treatment of heart defects |
| 09/16/2008 | US7425447 Host cells expressing 7C10 and 16C10 CD80-specific antibodies |
| 09/16/2008 | US7425444 Genome sequences and nucleotide sequences coding for the PWD circovirus polypeptides, such as the circovirus structural and non-structural polypeptides, vectors including the sequences, and cells transformed by the vectors |
| 09/16/2008 | US7425443 Treatment of diabetes with synthetic beta cells |
| 09/16/2008 | US7425442 Phytate polynucleotides and methods of use |
| 09/16/2008 | US7425438 Vector for anti-HPV vaccine and transformed microorganism by the vector |
| 09/16/2008 | US7425437 Human cells comprising sequence encoding early region-1 (E1) gene product of an adenovirus; cultured in suspension to very high densities under serum-free conditions |
| 09/16/2008 | US7425435 Nucleotide sequences coding sugar metabolism and oxidative phosphorylation (SMP) protein for preparation and generation of amino acid for use in foods, cosmetics and medicines; bioremediation; terpenoid biosynthesis |
| 09/16/2008 | US7425434 Allows the above microorganism to use cyclododecanol and cyclododecanone (12-membered ring compounds) as sole carbon source for growth and energy |
| 09/16/2008 | US7425433 Carboxylic acid reductase polypeptide, nucleotide sequence encoding same and methods of use |
| 09/16/2008 | US7425431 Polony fluorescent in situ sequencing beads |
| 09/16/2008 | US7425429 Method for the identification of tissue-specific regulatory sequences |
| 09/16/2008 | US7425428 Recombinant DNA construct for HIV envelope polypeptides and polypeptides produced thereby |
| 09/16/2008 | US7425423 Catalyzes template directed polymerization of DNA, possesses 3'-5'-exonuclease (proofreading) activity and is characterized by at least two-fold greater replication fidelity the DNA polymerase obtainable from Pyrococcus furiosus; dodecylpolyethylene glycol and/or ethylphenolpolyethylene glycol stabilizer |
| 09/16/2008 | US7425420 Using g-protein coupled receptor to identify modulators for prevention and treatment of schizophrenia and related psychoses |
| 09/16/2008 | US7425417 Comprises oligomers for detection of long terminal repeats of human lymphadenopathy associated virus and human T-cell leukemia/lymphoma virus; diagnosing viral disease/infection; contacting HIV-1 nucleic acid with capture oligomer and complexing; detecting amplified nucleic acid |
| 09/16/2008 | US7425416 Contacting target sequence and plurality of marker sequences to first and second set of oligonucleotides to anneal first set to target sequence or anneal second set to the marker sequences; elongation, detection; markers include single nucleotide polymorphisms or short tandem repeats |
| 09/16/2008 | US7425339 for use in immunosuppressive therapy, in particular as inhibitors of cytotoxic T cell responses; for graft versus host disease/autoimmune disorders |
| 09/16/2008 | US7425337 Alphavirus replicon vector systems |
| 09/16/2008 | US7425334 immunization of non-human animals to generate polyclonal antibodies against Nogo proteins, comprising administering an immunogenic protein that is free of all central nervous system myelin and recovering polyclonal antibodies from the animal |
| 09/16/2008 | US7425327 Choline binding proteins for anti-pneumococcal vaccines |
| 09/16/2008 | US7425325 binding ligands and proteins comprising amino acid sequences, having high specificity for the receptor zcytor17, used to induce proinflammatory cytokine production, for stimulating the immune system and proliferation and/or development of hematopoietic cells in vitro and in vivo; antibodies |
| 09/16/2008 | US7425324 Monocyte chemoattractant protein(MCP), mutants whose mucopolysaccharide binding site is eliminated by replacements, used to inhibit the migration and activation of leukocytes expressing their receptors; prevention of cancer, inflammatory, autoimmune and vascular diseases |
| 09/16/2008 | CA2467801C Nucleic sequences from the genome of salmonella typhi, and uses thereof particularly for the in vitro diagnosis of the presence of salmonella bacteria in foodstuffs |
| 09/16/2008 | CA2445358C Cells for detection of enteroviruses |
| 09/16/2008 | CA2410888C Nucleic acid isolation |
| 09/16/2008 | CA2409748C Soluble ctla4 mutant molecules and uses thereof |
| 09/16/2008 | CA2313609C Trypanosoma cruzi antigen, gene encoding therefor, and methods of detecting and treating chagas disease |
| 09/16/2008 | CA2298768C Stress tolerance and delayed senescence in plants |
| 09/16/2008 | CA2269640C Enzymatic cofactor cycling using soluble pyridine nucleotide transhydrogenase |
| 09/16/2008 | CA2252799C Antiviral ricin-like proteins |
| 09/16/2008 | CA2239519C Specific binding members for human carcinoembryonic antigen, materials and methods |
| 09/16/2008 | CA2202470C Intracellular isoform of the interleukin-1-receptor antagonist |
| 09/16/2008 | CA2132091C Antibodies to alphavbeta3 integrin |
| 09/16/2008 | CA2120732C Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction |
| 09/12/2008 | WO2008109837A2 Method for expression of small antiviral rna molecules with reduced cytotoxicity within a cell |
| 09/12/2008 | WO2008109816A1 Method for isolation of afterbirth derived cells |
| 09/12/2008 | WO2008109686A2 Non- infectious recombinant virus-like particles and their pharmaceutical applications |
| 09/12/2008 | WO2008109558A2 Nucleic acid compounds for inhibiting tlr gene expression and uses thereof |
| 09/12/2008 | WO2008109556A1 Nucleic acid compounds for inhibiting telomerase gene expression and uses thereof |
| 09/12/2008 | WO2008109555A2 Nucleic acid compounds for inhibiting nrg1 gene expression and uses thereof |
| 09/12/2008 | WO2008109553A1 Nucleic acid compounds for inhibiting ptpn11 gene expression and uses thereof |
| 09/12/2008 | WO2008109551A1 Nucleic acid compounds for inhibiting tacstd1 gene expression and uses thereof |
| 09/12/2008 | WO2008109548A2 Nucleic acid compounds for inhibiting tgfb gene expression and uses thereof |
| 09/12/2008 | WO2008109547A2 Nucleic acid compounds for inhibiting tymp gene expression and uses thereof |
| 09/12/2008 | WO2008109546A2 Nucleic acid compounds for inhibiting tgfbr gene expression and uses thereof |
| 09/12/2008 | WO2008109544A1 Nucleic acid compounds for inhibiting muc1 gene expression and uses thereof |
| 09/12/2008 | WO2008109534A1 Nucleic acid compounds for inhibiting ezh2 gene expression and uses thereof |
| 09/12/2008 | WO2008109532A2 Nucleic acid compounds for inhibiting fas gene expression and uses thereof |
| 09/12/2008 | WO2008109531A2 Nucleic acid compounds for inhibiting hsd11b1 expression and uses thereof |
| 09/12/2008 | WO2008109526A1 Nucleic acid compounds for inhibiting egr gene expression and uses thereof |
| 09/12/2008 | WO2008109520A2 Nucleic acid compounds for inhibiting cxc gene expression and uses thereof |
| 09/12/2008 | WO2008109518A1 Nucleic acid compounds for inhibiting wnt gene expression and uses thereof |
| 09/12/2008 | WO2008109516A2 Nucleic acid compounds for inhibiting ras gene expression and uses thereof |
| 09/12/2008 | WO2008109511A1 Nucleic acid compounds for inhibiting fcer2 gene expression and uses thereof |
| 09/12/2008 | WO2008109509A1 Nucleic acid compounds for inhibiting snca gene expression and uses thereof |
| 09/12/2008 | WO2008109506A1 Nucleic acid compounds for inhibiting jun gene expression and uses thereof |
| 09/12/2008 | WO2008109505A1 Nucleic acid compounds for inhibiting cd22 gene expression and uses thereof |
| 09/12/2008 | WO2008109503A1 Nucleic acid compounds for inhibiting ms4a1 gene expression and uses thereof |
| 09/12/2008 | WO2008109500A2 Nucleic acid compounds for inhibiting prkca gene expression and uses thereof |
| 09/12/2008 | WO2008109498A2 Nucleic acid compounds for inhibiting hdac gene expression and uses thereof |
| 09/12/2008 | WO2008109497A1 Nucleic acid compounds for inhibiting folh1 gene expression and uses thereof |
| 09/12/2008 | WO2008109495A2 Nucleic acid compounds for inhibiting cd40 gene expression and uses thereof |
| 09/12/2008 | WO2008109494A1 Nucleic acid compounds for inhibiting stat3 gene expression and uses thereof |
| 09/12/2008 | WO2008109493A2 Nucleic acid compounds for inhibiting cd19 gene expression and uses thereof |
| 09/12/2008 | WO2008109492A1 Nucleic acid compounds for inhibiting igf1r gene expression and uses thereof |
| 09/12/2008 | WO2008109490A2 Nucleic acid compounds for inhibiting chek1 gene expression and uses thereof |
| 09/12/2008 | WO2008109488A1 Nucleic acid compounds for inhibiting angpt2 gene expression and uses thereof |
| 09/12/2008 | WO2008109487A2 Nucleic acid compounds for inhibiting mme gene expression and uses thereof |
| 09/12/2008 | WO2008109475A1 Nucleic acid compounds for inhibiting sirt2 gene expression and uses thereof |
| 09/12/2008 | WO2008109474A1 Nucleic acid compounds for inhibiting fgf2 gene expression and uses thereof |
| 09/12/2008 | WO2008109473A1 Nucleic acid compounds for inhibiting abcb1 gene expression and uses thereof |
| 09/12/2008 | WO2008109472A2 Nucleic acid compounds for inhibiting pcsk9 gene exprression and uses thereof |
| 09/12/2008 | WO2008109470A2 Nucleic acid compounds for inhibiting ptpn1 gene expression and uses thereof |
| 09/12/2008 | WO2008109469A2 Nucleic acid compounds for inhibiting pcna gene expression and uses thereof |
| 09/12/2008 | WO2008109468A1 Nucleic acid compounds for inhibiting mmp gene expression and uses thereof |
| 09/12/2008 | WO2008109465A2 Nucleic acid compounds for inhibiting fgfr gene expression and uses thereof |
| 09/12/2008 | WO2008109461A1 Nucleic acid compounds for inhibiting cd3 gene expression and uses thereof |
| 09/12/2008 | WO2008109460A2 Nucleic acid compounds for inhibiting ctnnb1 gene expression and uses thereof |
| 09/12/2008 | WO2008109456A1 Nucleic acid compounds for inhibiting dgat gene expression and uses thereof |
| 09/12/2008 | WO2008109455A1 Nucleic acid compounds for inhibiting mapk3 gene expression and uses thereof |
| 09/12/2008 | WO2008109454A2 Nucleic acid compounds for inhibiting fos gene expression and uses thereof |
| 09/12/2008 | WO2008109452A1 Nucleic acid compounds for inhibiting tie gene expression and uses thereof |
| 09/12/2008 | WO2008109450A2 Nucleic acid compounds for inhibiting id-1 gene expression and uses thereof |
| 09/12/2008 | WO2008109449A1 Nucleic acid compounds for inhibiting bcl2 gene expression and uses thereof |
| 09/12/2008 | WO2008109447A1 Nucleic acid compounds for inhibiting met gene expression and uses thereof |
| 09/12/2008 | WO2008109443A2 Nucleic acid compounds for inhibiting cdk2 gene expression and uses thereof |
| 09/12/2008 | WO2008109432A2 Therapeutic targeting of interleukins using sirna in neutral liposomes |
| 09/12/2008 | WO2008109398A1 T4 bacteriophage bound to a substrate |
| 09/12/2008 | WO2008109382A1 Nucleic acid compounds for inhibiting pkn3 gene expression and uses thereof |
| 09/12/2008 | WO2008109381A2 Nucleic acid compounds for inhibiting hif1a gene expression and uses thereof |
| 09/12/2008 | WO2008109380A2 Nucleic acid compounds for inhibiting vegfr family gene expression and uses thereof |
| 09/12/2008 | WO2008109379A1 Nucleic acid compounds for inhibiting il17a gene expression and uses thereof |
| 09/12/2008 | WO2008109378A2 Nucleic acid compounds for inhibiting pdgfr gene expression and uses thereof |